Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Daniel Thomas

Name: Lenzilumab and azacitidine in proliferative CMML: insights from the PREACH-M study
Uploaded: 2023-12-11T00:00:00Z
Duration: 2 min 28 s

The University of Adelaide

ASH 2023

San Diego, CA / Online • 9 Dec 2023

Daniel Thomas

Cookie settings